0001017491-17-000015.txt : 20170106 0001017491-17-000015.hdr.sgml : 20170106 20170106193033 ACCESSION NUMBER: 0001017491-17-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170105 FILED AS OF DATE: 20170106 DATE AS OF CHANGE: 20170106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APRICUS BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001017491 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870449967 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 222-8041 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: NEXMED INC DATE OF NAME CHANGE: 19970311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morton Neil CENTRAL INDEX KEY: 0001670896 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22245 FILM NUMBER: 17515543 MAIL ADDRESS: STREET 1: C/O APRICUS BIOSCIENCES, INC. STREET 2: 11975 EL CAMINO REAL, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 wf-form4_148374902071939.xml FORM 4 X0306 4 2017-01-05 0 0001017491 APRICUS BIOSCIENCES, INC. APRI 0001670896 Morton Neil 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 0 1 0 0 SVP, Chief Business Officer Common Stock 2017-01-05 4 A 0 75000 A 87949 D Award of 75,000 Restricted Stock Units ("RSUs") under the Issuer's 2012 Stock Long Term Incentive Plan with half of the underlying shares vesting in the first open trading window following the Issuer's receipt of marketing approval of Vitaros in the United States by the Food and Drug Administration and the other half of the underlying shares fully vesting on November 30, 2018, subject to the Reporting Person's continued employment or service to the Issuer through such date and subject to accelerated vesting upon a change in control of the Issuer. Not applicable. /s/ Richard W. Pascoe by power of attorney for Neil Morton 2017-01-06